RNA biology
Natural antisense transcripts, gene regulation, and non-coding RNA mechanisms.
Physician-scientist · Laboratory founder · M.D., Ph.D.
Advancing genetic science into diagnostic practice.
Dr. Mohammad Faghihi is a medical geneticist and RNA researcher whose career connects molecular discovery, neurological disease research, high-complexity diagnostics, and scientific leadership.
M.D.Clinical medicine
Ph.D.Karolinska Institutet
15+ yearsNeurological disease research
High-complexityMolecular laboratory leadership
Scientific leadership
From molecular discovery to clinical utility.
Dr. Faghihi’s work brings together academic research, laboratory development, quality systems, and the practical delivery of molecular testing. His record includes appointments at Scripps Florida and the University of Miami, research into neurological and neurodevelopmental disorders, and leadership of a high-complexity diagnostics laboratory.
Human genetics
Research connecting molecular pathways with neurological and inherited disorders.
Diagnostics
Assay implementation, laboratory quality, genetic test review, and clinical reporting.
Laboratory founder & director
Building diagnostic capacity with scientific rigor.
As founder and director of a molecular diagnostics laboratory, Dr. Faghihi led work spanning genetic testing, RT-PCR assay implementation, laboratory quality, and scientific review.
01High-complexity molecular laboratory leadership
02FDA-documented SARS-CoV-2 RT-PCR diagnostic work
03Clinical genetic testing and result interpretation
Research portfolio
Deep expertise across RNA and neurological genetics.
His research examines how coding and non-coding elements of the genome influence gene regulation, neurological disease, and opportunities for diagnostic and therapeutic innovation.
01 · RNA biology
Natural antisense transcripts
Mechanisms that regulate gene expression and shape disease-relevant molecular pathways.
02 · NeuroscienceNeurological disease genetics
Research involving Alzheimer’s disease, Parkinson’s disease, autism, and fragile X syndrome.
03 · TranslationPatents and molecular innovation
Inventorship and applied work extending molecular insights toward new diagnostic and therapeutic strategies.
Selected scientific record
Peer-reviewed work in leading biomedical journals.
Selected publications document contributions to non-coding RNA biology, Alzheimer’s disease mechanisms, autism research, hereditary spastic paraplegia, and gene regulation.
Rare and common genetic contributors to familial hypercholesterolemia
Read the research featureRegulatory roles of natural antisense transcripts
View PubMed recordUBAP1 mutations and hereditary spastic paraplegia
View PubMed recordPublication lists and citation counts change over time. The public Google Scholar and PubMed profiles provide the current record.
Education & academic leadership
Clinical training reinforced by world-class biomedical research.
Medical training at Shiraz University of Medical Sciences was followed by doctoral work at Karolinska Institutet and research and teaching in the United States.
His academic work has included university teaching and mentorship of undergraduate, graduate, and postdoctoral researchers across genetics, epigenetics, and neurological disease.
Read the professional biographyScientific record
Explore the research, publications, and laboratory work.
Review source-backed pages covering Dr. Faghihi’s research, patents, education, and molecular diagnostics leadership.